Chamomile — Benefits Deep Dive

Benefits — scientific infographic poster

Matricaria chamomilla (German chamomile) is one of the most-consumed herbal teas on Earth — an estimated one million cups are brewed every day — with a continuous documented use record stretching back to the ancient Egyptians, who dedicated it to the sun god Ra for fevers. The single most important active is apigenin, a flavonoid that binds the benzodiazepine-recognition site on the gamma-aminobutyric acid-A receptor with measurable affinity — a real molecular pharmacology that explains why a nighttime cup of chamomile tea is not merely a placebo ritual. The centuries-old tradition has been tested in modern randomized controlled trials: Adib-Hajbaghery 2017 in elderly nursing-home residents, Chang 2016 in postpartum women, Zick 2011 in chronic insomnia (a 34-patient pilot that found no significant sleep-diary differences from placebo), Amsterdam 2009 in generalized anxiety disorder (with a 2012 re-analysis of the same trial's depression scores), and Patzelt-Wenczler 2000 in atopic dermatitis (against hydrocortisone and a placebo cream, with a marginal difference from placebo). Four benefit pages below explore the four domains where chamomile has been studied: sleep, anxiety, digestive/irritable bowel syndrome (IBS) symptoms, and topical skin healing.

Deep-Dive Articles

😴

Sleep Quality

Apigenin binds the benzodiazepine site of the gamma-aminobutyric acid-A receptor, producing a mild anxiolytic and sleep-promoting effect without the dependency, tolerance, or cognitive impairment of pharmaceutical benzodiazepines. The Adib-Hajbaghery 2017 randomized controlled trial (RCT) in elderly nursing-home residents and the Chang 2016 randomized controlled trial in postpartum women document measurable sleep-quality improvement on validated instruments (PSQI, Athens Insomnia Scale); the Zick 2011 pilot randomized controlled trial in 34 adults with chronic primary insomnia found no significant differences from placebo in sleep-diary measures, with modest, non-significant benefits on daytime functioning. Comparison with over-the-counter (OTC) diphenhydramine and doxylamine.

Read the deep dive →
🧘

Anxiety Relief

The Amsterdam 2009 randomized double-blind placebo-controlled trial of standardized chamomile extract (1.2% apigenin) in generalized anxiety disorder showed a modest, statistically significant (P = 0.047) greater reduction in Hamilton Anxiety scores than placebo in 57 patients. A 2012 secondary analysis of the same trial found a significantly greater reduction in Hamilton Depression scores with chamomile than with placebo. Apigenin's benzodiazepine-like binding mechanism, why it is partial-agonist (not full agonist like alprazolam), and what that means for safety and tolerability.

Read the deep dive →
🍽️

Digestive Health & Irritable Bowel Syndrome

Direct smooth-muscle antispasmodic mechanism via bisabolol and the flavonoid fraction, the Savino 2005 infant colic trial (an extract of chamomile, fennel and lemon balm in 93 breastfed colicky infants), chamomile as one of the herbs in a nine-herb liquid digestive preparation for functional dyspepsia and irritable bowel syndrome, and the use of chamomile as an adjunct for ulcerative colitis remission maintenance in pilot data.

Read the deep dive →
🧴

Skin Healing

The Patzelt-Wenczler 2000 head-to-head trial of topical chamomile cream against 0.5% hydrocortisone in atopic dermatitis, the episiotomy and post-surgical wound-healing literature, alpha-bisabolol as the principal anti-inflammatory and skin-soothing terpenoid, chamazulene as the deep-blue azulene anti-inflammatory pigment of chamomile essential oil, and topical formulation considerations.

Read the deep dive →
👄

Mouth Sores From Cancer Treatment

Chamomile mouthwash for oral mucositis caused by chemotherapy, radiation and stem-cell transplant: the 1996 phase III placebo-controlled trial in 164 patients on 5-fluorouracil that found no difference, the later small trials, the network meta-analyses comparing mouthwashes, what the MASCC/ISOO guideline covers, and the daisy-family allergy and warfarin reports.

Read the deep dive →

Back to Table of Contents

Table of Contents

  1. Deep-Dive Articles
  2. Why Chamomile Produces Effects (Apigenin, Bisabolol, Chamazulene)
  3. Research Papers: Sleep Quality
  4. Research Papers: Anxiety Relief
  5. Research Papers: Digestive and Irritable Bowel Syndrome
  6. Research Papers: Skin Healing
  7. Research Papers: Mechanism (Apigenin, Bisabolol, Chamazulene)
  8. External Authoritative Resources
  9. Connections
  10. Featured Videos

Why Chamomile Produces Effects (Apigenin, Bisabolol, Chamazulene)

Chamomile is not a one-active herb. Three structurally distinct active classes account for the bulk of its documented clinical effects, and each maps to a different therapeutic domain.

  1. Apigenin (flavonoid) — the benzodiazepine-receptor binder. Apigenin is a 4′,5,7-trihydroxyflavone present at ~0.8–1.2% of dried flower weight, mostly as the 7-O-glucoside that is hydrolyzed to the aglycone in the gut. The aglycone crosses the blood-brain barrier and binds the benzodiazepine-recognition site on the alpha-1/alpha-2 subunit interface of the gamma-aminobutyric acid-A receptor with measurable, low-micromolar affinity. Unlike a full agonist (alprazolam, diazepam), apigenin appears to act as a partial agonist or weak modulator — producing a mild anxiolytic and sleep-promoting effect without the deep sedation, cognitive impairment, tolerance, dependency, or rebound anxiety of pharmaceutical benzodiazepines. This is the mechanism behind both the sleep-quality and anxiety benefits.
  2. Alpha-bisabolol (sesquiterpenoid) — the smooth-muscle antispasmodic and skin-soothing terpenoid. Bisabolol is the dominant terpene in German chamomile essential oil (typically 25–65% of the oil). It is a direct smooth-muscle relaxant in isolated intestinal preparations and has well-documented anti-inflammatory, antiulcer, and anti-irritation activity in animal models and topical human trials. Bisabolol is the principal driver of the antispasmodic / irritable bowel syndrome benefit and the topical skin-healing benefit, and it appears in commercial cosmetic products (often synthesized rather than chamomile-extracted) precisely because of its skin-soothing track record.
  3. Chamazulene (sesquiterpene azulene) — the anti-inflammatory deep-blue pigment. Chamomile essential oil is famously a deep inky blue color. The pigment is chamazulene, which is not present in the intact plant — it forms during steam distillation from the precursor matricin. Chamazulene inhibits leukotriene B4 synthesis (5-lipoxygenase pathway) and has documented anti-inflammatory activity in topical inflammation models. It contributes to both the antispasmodic effect (synergistically with bisabolol) and to the topical anti-inflammatory effect on inflamed skin.

Most commercial chamomile tea is dried flower head, infused. Hot water extracts the water-soluble apigenin glycosides and a fraction of the flavonoids; the bulk of the essential-oil terpenoids (bisabolol, chamazulene) require a longer steep with a tightly-covered cup to retain the volatile components. Standardized extracts (capsule form, used in most modern randomized controlled trials, RCTs) are titrated to 1.2% apigenin and typically dosed at 220–1100 mg/day. Topical preparations are titrated to alpha-bisabolol and/or chamazulene content. The three actives co-occur in the intact plant but emphasize different therapeutic uses based on preparation, route, and dose.

Back to Table of Contents

Research Papers: Sleep Quality

  1. Adib-Hajbaghery M, Mousavi SN (2017). The effects of chamomile extract on sleep quality among elderly people: A clinical trial. Complementary Therapies in Medicine. — PubMed: Adib-Hajbaghery 2017 elderly RCT
  2. Chang SM, Chen CH (2016). Effects of an intervention with drinking chamomile tea on sleep quality and depression in sleep disturbed postnatal women. Journal of Advanced Nursing. — PubMed: Chang 2016 postpartum RCT
  3. Zick SM, Wright BD, Sen A, Arnedt JT (2011). Preliminary examination of the efficacy and safety of a standardized chamomile extract for chronic primary insomnia: a randomized placebo-controlled pilot study. BMC Complementary and Alternative Medicine 11:78. — PubMed PMID: 21939549
  4. Apigenin and the benzodiazepine receptor binding site — PubMed: Apigenin BZD receptor
  5. Chamomile in pediatric and elderly sleep disturbance — PubMed: Pediatric and elderly sleep

Back to Table of Contents

Research Papers: Anxiety Relief

  1. Amsterdam JD, Li Y, Soeller I, Rockwell K, Mao JJ, Shults J (2009). A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder. Journal of Clinical Psychopharmacology 29(4):378–82. — PubMed PMID: 19593179
  2. Amsterdam JD, Shults J, Soeller I, Mao JJ, Rockwell K, Newberg AB (2012). Chamomile (Matricaria recutita) may provide antidepressant activity in anxious, depressed humans: an exploratory study. Alternative Therapies in Health and Medicine 18(5):44–9 (a secondary analysis of the 2009 trial). — PubMed PMID: 22894890
  3. Mao JJ et al. (2016). Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder. Phytomedicine. — PubMed: Mao 2016 long-term GAD
  4. Apigenin anxiolytic mechanism: animal model and BZD-site binding — PubMed: Apigenin anxiolytic animal model

Back to Table of Contents

Research Papers: Digestive and Irritable Bowel Syndrome

  1. Savino F, Cresi F, Castagno E, Silvestro L, Oggero R (2005). A randomized double-blind placebo-controlled trial of a standardized extract of Matricariae recutita, Foeniculum vulgare and Melissa officinalis (ColiMil) in the treatment of breastfed colicky infants. Phytotherapy Research 19(4):335–40. — PubMed PMID: 16041731
  2. Nine-herb liquid digestive preparation including chamomile for functional dyspepsia — PubMed: Nine-herb preparation for dyspepsia
  3. Chamomile antispasmodic activity in isolated smooth muscle — PubMed: Chamomile antispasmodic in vitro
  4. Nine-herb liquid digestive preparation for irritable bowel syndrome adjunct treatment — PubMed: Nine-herb preparation for irritable bowel syndrome

Back to Table of Contents

Research Papers: Skin Healing

  1. Patzelt-Wenczler R, Ponce-Pöschl E (2000). Proof of efficacy of Kamillosan(R) cream in atopic eczema. European Journal of Medical Research 5(4):171–5 (a partially double-blind half-side comparison against 0.5% hydrocortisone and a placebo cream; the first author's listed affiliation is the cream's manufacturer). — PubMed PMID: 10799352
  2. Chamomile cream vs almond ointment for episiotomy wound healing — PubMed: Chamomile episiotomy healing
  3. Topical chamomile for radiation dermatitis adjunct — PubMed: Chamomile radiation dermatitis
  4. Alpha-bisabolol anti-inflammatory activity in skin — PubMed: Alpha-bisabolol topical
  5. Chamomile mouthwash for chemotherapy-induced oral mucositis — PubMed: Chamomile mouthwash mucositis

Back to Table of Contents

Research Papers: Mechanism (Apigenin, Bisabolol, Chamazulene)

  1. Apigenin: a flavonoid with diverse pharmacological activity — PubMed: Apigenin pharmacology review
  2. Apigenin pharmacokinetics and bioavailability — PubMed: Apigenin pharmacokinetics
  3. Chamazulene from matricin during steam distillation — PubMed: Chamazulene biosynthesis
  4. Chamomile essential oil composition and analytical profiling — PubMed: Essential oil composition
  5. Srivastava JK et al. (2010). Chamomile: A herbal medicine of the past with bright future. Molecular Medicine Reports. — PubMed: Srivastava 2010 review

Back to Table of Contents

External Authoritative Resources

Back to Table of Contents

Connections

Back to Table of Contents